Modulation of circulating macrophage migration inhibitory factor in the elderly

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Rammos, Christos ^a   Hendgen Cotta, Ulrike B ^a   Pohl, Julia ^a   Totzeck, Matthias ^a   Luedike, Peter ^a   Schulze, Volker T ^a   Kelm, Malte ^a   Rassaf, Tienush ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; SODIUM CHLORIDE; SODIUM NITRATE; NITRIC ACID DERIVATIVE;

ADULT; AGING; ARTERIAL STIFFNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HEMODYNAMICS; HUMAN; INFLAMMATION; KIDNEY DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; MIDDLE AGED; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; AGED; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECTS;

AGED; BLOOD PRESSURE; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; NITRATES;

EID: 84904793603     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/582586     Document Type: Article

References (54)

1. Lakatta E. G., Levy D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation 2003 107 1 139 146 10.1161/01.CIR.0000048892.83521.58 2-s2.0-0037422592 (Pubitemid 36070946)
2. Kaess B. M., Rong J., Larson M. G., Hamburg N. M., Vita J. A., Levy D., Benjamin E. J., Vasan R. S., Mitchell G. F., Aortic stiffness, blood pressure progression, and incident hypertension. The Journal of the American Medical Association 2012 308 9 875 881 10.1001/2012.jama.10503 2-s2.0-84865701980
3. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M. P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G. C., Salvioli S., Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Ageing and Development 2007 128 1 92 105 10.1016/j.mad.2006.11.016 2-s2.0-33846111415 (Pubitemid 46073065)
4. Baylis D., Bartlett D. B., Patel H. P., Roberts H. C., Understanding how we age: insights into inflammaging. Longevity & Healthspan 2013 2, article 8 10.1186/2046-2395-2-8
5. Salminen A., Huuskonen J., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T., Activation of innate immunity system during aging: NF- B signaling is the molecular culprit of inflamm-aging. Ageing Research Reviews 2008 7 2 83 105 10.1016/j.arr.2007.09.002 2-s2.0-40949123149 (Pubitemid 351418294)
6. Bernhagen J., Krohn R., Lue H., Gregory J. L., Zernecke A., Koenen R. R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S. R., Bucala R., Hickey M. J., Weber C., MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 2007 13 5 587 596 10.1038/nm1567 2-s2.0-34249066942 (Pubitemid 46828480)
7. Burger-Kentischer A., Goebel H., Seiler R., Fraedrich G., Schaefer H. E., Dimmeler S., Kleemann R., Bernhagen J., Ihling C., Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002 105 13 1561 1566 10.1161/01.CIR.0000012942.49244.82 2-s2.0-0037007137 (Pubitemid 34297633)
8. Zernecke A., Bernhagen J., Weber C., Macrophage migration inhibitory factor in cardiovascular disease. Circulation 2008 117 12 1594 1602 10.1161/CIRCULATIONAHA.107.729125 2-s2.0-41149093871 (Pubitemid 351440647)
9. Rammos C., Hendgen-Cotta U. B., Sobierajski J., Adamczyk S., Hetzel G. R., Kleophas W., Dellanna F., Kelm M., Rassaf T., Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease. International Journal of Cardiology 2013 168 6 5249 5256 10.1016/j.ijcard.2013.08.021 2-s2.0-84882304285
10. Fleg J. L., Aronow W. S., Frishman W. H., Cardiovascular drug therapy in the elderly: benefits and challenges. Nature Reviews Cardiology 2011 8 1 13 28 10.1038/nrcardio.2010.162 2-s2.0-78651487001
11. Jeffery I. B., O'Toole P. W., Diet-microbiota interactions and their implications for healthy living. Nutrients 2013 5 1 234 252 10.3390/nu5010234 2-s2.0-84872860742
12. Sofi F., Cesari F., Abbate R., Gensini G. F., Casini A., Adherence to Mediterranean diet and health status: meta-analysis. British Medical Journal 2008 337, article a1344 10.1136/bmj.a1344 2-s2.0-52449087288
13. Larsen F. J., Ekblom B., Sahlin K., Lundberg J. O., Weitzberg E., Effects of dietary nitrate on blood pressure in healthy volunteers. The New England Journal of Medicine 2006 355 26 2792 2793 10.1056/NEJMc062800 2-s2.0-33845877743
14. Lundberg J. O., Weitzberg E., Gladwin M. T., The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nature Reviews Drug Discovery 2008 7 2 156 167 10.1038/nrd2466 2-s2.0-38849162730 (Pubitemid 351194063)
15. Totzeck M., Hendgen-Cotta U. B., Luedike P., Berenbrink M., Klare J. P., Steinhoff H., Semmler D., Shiva S., Williams D., Kipar A., Gladwin M. T., Schrader J., Kelm M., Cossins A. R., Rassaf T., Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 2012 126 3 325 334 10.1161/CIRCULATIONAHA.111.087155 2-s2.0-84863927306
16. Gladwin M. T., Schechter A. N., Kim-Shapiro D. B., The emerging biology of the nitrite anion. Nature Chemical Biology 2005 1 6 308 314
17. Rassaf T., Poll L. W., Brouzos P., Lauer T., Totzeck M., Kleinbongard P., Gharini P., Andersen K., Schulz R., Heusch G., Mödder U., Kelm M., Positive effects of nitric oxide on left ventricular function in humans. European Heart Journal 2006 27 14 1699 1705 10.1093/eurheartj/ehl096 2-s2.0-33745778223 (Pubitemid 44025358)
18. Rammos C., Hendgen-Cotta U. B., Sobierajski J., Bernard A., Kelm M., Rassaf T., Dietary nitrate reverses vascular dysfunction in older adults with moderately increased cardiovascular risk. Journal of the American College of Cardiology 2014 63 15 1584 1585 10.1016/j.jacc.2013.08.691
19. Sobierajski J., Hendgen-Cotta U. B., Luedike P., Stock P., Rammos C., Meyer C., Kraemer S., Stoppe C., Bernhagen J., Kelm M., Rassaf T., Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels. Free Radical Biology and Medicine 2013 63 236 242 10.1016/j.freeradbiomed.2013.05.018 2-s2.0-84879222930
20. Pauca A. L., O'Rourke M. F., Kon N. D., Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001 38 4 932 937 10.1161/hy1001.096106 2-s2.0-0035724737 (Pubitemid 34258696)
21. Wannamethee S. G., Welsh P., Lowe G. D., Gudnason V., di Angelantonio E., Lennon L., Rumley A., Whincup P. H., Sattar N., N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. Journal of the American College of Cardiology 2011 58 1 56 64 10.1016/j.jacc.2011.02.041 2-s2.0-79959499350
22. Tsimikas S., Willeit P., Willeit J., Santer P., Mayr M., Xu Q., Mayr A., Witztum J. L., Kiechl S., Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. Journal of the American College of Cardiology 2012 60 21 2218 2229 10.1016/j.jacc.2012.08.979 2-s2.0-84869090395
23. Sell H., Habich C., Eckel J., Adaptive immunity in obesity and insulin resistance. Nature Reviews Endocrinology 2012 8 12 709 716 10.1038/nrendo.2012. 114 2-s2.0-84870058819
24. Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. The New England Journal of Medicine 1997 336 14 973 979 10.1056/NEJM199704033361401 2-s2.0-0030956673 (Pubitemid 27152782)
25. Iseki K., Tozawa M., Yoshi S., Fukiyama K., Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrology Dialysis Transplantation 1999 14 8 1956 1960 10.1093/ndt/14.8.1956 2-s2.0-0032784499 (Pubitemid 29358894)
26. Schober A., Bernhagen J., Weber C., Chemokine-like functions of MIF in atherosclerosis. Journal of Molecular Medicine 2008 86 7 761 770 10.1007/s00109-008-0334-2 2-s2.0-46149091057
27. Asare Y., Schmitt M., Bernhagen J., The vascular biology of macrophage migration inhibitory factor (MIF): expression and effects in inflammation, atherogenesis and angiogenesis. Thrombosis and Haemostasis 2013 109 3 391 398 10.1160/TH12-11-0831 2-s2.0-84874770590
28. Chen L., Yang G., Zhang X., Wu J., Gu Q., Wei M., Yang J., Zhu Y., Guan Y., Induction of MIF expression by oxidized LDL via activation of NF- B in vascular smooth muscle cells. Atherosclerosis 2009 207 2 428 433 10.1016/j.atherosclerosis.2009.05.021 2-s2.0-70450257720
29. Rammos C., Hendgen-Cotta U. B., Deenen R., Age-related vascular gene expression profiling in mice. Mechanisms of Ageing and Development 2014 135 15 23
30. Ridker P. M., Stampfer M. J., Rifai N., Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. The Journal of the American Medical Association 2001 285 19 2481 2485 10.1001/jama.285.19.2481 2-s2.0-0035897688 (Pubitemid 32433842)
31. Barter P. J., Nicholls S., Rye K., Anantharamaiah G. M., Navab M., Fogelman A. M., Antiinflammatory properties of HDL. Circulation Research 2004 95 8 764 772 10.1161/01.RES.0000146094.59640.13 2-s2.0-6344253356 (Pubitemid 39390578)
32. Burger-Kentischer A., Göbel H., Kleemann R., Zernecke A., Bucala R., Leng L., Finkelmeier D., Geiger G., Schaefer H. E., Schober A., Weber C., Brunner H., Rütten H., Ihling C., Bernhagen J., Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 2006 184 1 28 38 10.1016/j.atherosclerosis.2005.03.028 2-s2.0-28344441098 (Pubitemid 41721066)
33. Harper J. M., Wilkinson J. E., Miller R. A., Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction. The FASEB Journal 2010 24 7 2436 2442 10.1096/fj.09-152223 2-s2.0-77954444618
34. Appel L. J., Moore T. J., Obarzanek E., A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. The New England Journal of Medicine 1997 336 16 1117 1124
35. Appel L. J., Sacks F. M., Carey V. J., Obarzanek E., Swain J. F., Miller E. R. III, Conlin P. R., Erlinger T. P., Rosner B. A., Laranjo N. M., Charleston J., McCarron P., Bishop L. M., Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. Journal of the American Medical Association 2005 294 19 2455 2464 10.1001/jama.294.19.2455 2-s2.0-27744494434 (Pubitemid 41627923)
36. Schroeter H., Heiss C., Balzer J., Kleinbongard P., Keen C. L., Hollenberg N. K., Sies H., Kwik-Uribe C., Schmitz H. H., Kelm M., (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences of the United States of America 2006 103 4 1024 1029 10.1073/pnas.0510168103 2-s2.0-32244437985 (Pubitemid 43212215)
37. Hendgen-Cotta U. B., Luedike P., Totzeck M., Kropp M., Schicho A., Stock P., Rammos C., Niessen M., Heiss C., Lundberg J. O., Weitzberg E., Kelm M., Rassaf T., Dietary nitrate supplementation improves revascularization in chronic ischemia. Circulation 2012 126 16 1983 1992 10.1161/CIRCULATIONAHA.112.112912 2-s2.0-84867572397
38. Hendgen-Cotta U. B., Kelm M., Rassaf T., A highlight of myoglobin diversity: the nitrite reductase activity during myocardial ischemia- reperfusion. Nitric Oxide-Biology and Chemistry 2010 22 2 75 82 10.1016/j.niox.2009.10.003 2-s2.0-75149146434
39. Rassaf T., Totzeck M., Hendgen-Cotta U. B., Shiva S., Heusch G., Kelm M., Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circulation Research 2014 114 10 1601 1610 10.1161/CIRCRESAHA. 114.303822
40. Sindler A. L., Devan A. E., Fleenor B. S., Seals D. R., Inorganic nitrite supplementation for healthy arterial aging. Journal of Applied Physiology 2014 116 5 463 477
41. Bahra M., Kapil V., Pearl V., Ghosh S., Ahluwalia A., Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide: Biology and Chemistry 2012 26 4 197 202 10.1016/j.niox.2012.01.004 2-s2.0-84861314928
42. Yeboah J., Crouse J. R., Hsu F., Burke G. L., Herrington D. M., Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation 2007 115 18 2390 2397 10.1161/CIRCULATIONAHA.106.678276 2-s2.0-34248196019 (Pubitemid 46717961)
43. Hansen T. W., Staessen J. A., Torp-Pedersen C., Rasmussen S., Thijs L., Ibsen H., Jeppesen J., Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006 113 5 664 670 10.1161/CIRCULATIONAHA.105.579342 2-s2.0-33644863316
44. Luedike P., Hendgen-Cotta U. B., Sobierajski J., Totzeck M., Reeh M., Dewor M., Lue H., Krisp C., Wolters D., Kelm M., Bernhagen J., Rassaf T., Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation 2012 125 15 1880 1889 10.1161/CIRCULATIONAHA.111.069104 2-s2.0-84859764361
45. Rassaf T., Weber C., Bernhagen J., Macrophage migration inhibitory factor in myocardial ischemia/reperfusion injury. Cardiovascular Research 2014 102 2 321 328 10.1093/cvr/cvu071
46. Santoro A., Pini E., Scurti M., Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project's conceptual framework and design. Mechanisms of Ageing and Development 2014 136-137 3 13 10.1016/j.mad.2013.12.001
47. Sindler A. L., Fleenor B. S., Calvert J. W., Marshall K. D., Zigler M. L., Lefer D. J., Seals D. R., Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell 2011 10 3 429 437 10.1111/j.1474-9726.2011.00679.x 2-s2.0-79955960774
48. Roman M. J., Devereux R. B., Schwartz J. E., Lockshin M. D., Paget S. A., Davis A., Crow M. K., Sammaritano L., Levine D. M., Shankar B., Moeller E., Salmon J. E., Arterial stiffness in chronic inflammatory diseases. Hypertension 2005 46 1 194 199 10.1161/01.HYP.0000168055.89955.db 2-s2.0-21744453956 (Pubitemid 40946513)
49. Laurent S., Cockcroft J., van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., Pannier B., Vlachopoulos C., Wilkinson I., Struijker-Boudier H., Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal 2006 27 21 2588 2605 10.1093/eurheartj/ehl254 2-s2.0-33750318148 (Pubitemid 44627304)
50. McEniery C. M., Hall I. R., Qasem A., Wilkinson I. B., Cockcroft J. R., Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity. The Anglo-Cardiff Collaborative Trial (ACCT). Journal of the American College of Cardiology 2005 46 9 1753 1760 10.1016/j.jacc.2005.07.037 2-s2.0-27444441183 (Pubitemid 41531635)
51. Oliver J. J., Webb D. J., Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 554 566 10.1161/01.ATV.0000060460.52916.D6 2-s2.0-0037389062 (Pubitemid 36438066)
52. Mancia G., de Backer G., Dominiczak A., 2007 Guidelines for the management of arterial hypertension. The Task Forc e for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2007 28 12 1462 1536 2-s2.0-38449109981
53. Kapil V., Milsom A. B., Okorie M., Maleki-Toyserkani S., Akram F., Rehman F., Arghandawi S., Pearl V., Benjamin N., Loukogeorgakis S., MacAllister R., Hobbs A. J., Webb A. J., Ahluwalia A., Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived No. Hypertension 2010 56 2 274 281 10.1161/HYPERTENSIONAHA.110.153536 2-s2.0-77955476126
54. Pirro M., Schillaci G., Savarese G., Gemelli F., Mannarino M. R., Siepi D., Bagaglia F., Mannarino E., Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. The European Journal of Cardiovascular Prevention and Rehabilitation 2004 11 6 497 502 10.1097/00149831-200412000-00009 2-s2.0-11844300428 (Pubitemid 40096852)